Abstract
We describe a 64-year-old patient with multiple myeloma who developed a sudden sensorineural hearing loss shortly after receiving chemotherapy with vincristine. Ototoxicity is not a known side effect of this drug. It would be of interest to perform repeated audiograms on patients receiving vincristine, in order to appreciate the actual ototoxicity of this drug.
Original language | English |
---|---|
Pages (from-to) | 320-321 |
Number of pages | 2 |
Journal | Blut |
Volume | 61 |
Issue number | 5 |
DOIs | |
State | Published - 1 Nov 1990 |
Keywords
- Hearing loss
- Ototoxicity
- Vincristine
ASJC Scopus subject areas
- Hematology